Abstract
The Ashby Commission reports propose, inter alia, the setting up of a data bank to enable pre-determination of the potential hazards associated with pollutants of known chemical type. The pharmaceutical industry faces a parallel problem with respect to new candidate drugs; and also the converse situation in which it seeks new molecular structures having prescribed (useful) biological activity. The mechanics of establishing such a comprehensive index are discussed, together with the extent, based on specific examples, to which it can be applied to the Ashby proposals.

This publication has 0 references indexed in Scilit: